tradingkey.logo
tradingkey.logo
Search

Evotec SE

EVO
Add to Watchlist
1.530USD
-0.010-0.65%
Close 09-24 16:00(ET)
543.75MMarket Cap
LossP/E TTM

About Evotec SE Company

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Evotec SE Profile

Ticker SymbolEVO
Company nameEvotec SE
IPO dateOct 11, 1999
CEOWojczewski (Christian)
Number of employees4827
Security typeDepository Receipt
Fiscal year-endOct 11
AddressEssener Bogen 7
CityHAMBURG
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryGermany
Postal code22419
Phone4940560810
Websitehttps://www.evotec.com/
Ticker SymbolEVO
IPO dateOct 11, 1999
CEOWojczewski (Christian)

Company Executives of Evotec SE

Name
Name/Position
Position
Shareholding
Change
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Wesley Wheeler
Mr. Wesley Wheeler
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Ashiq H. Khan
Dr. Ashiq H. Khan
Chief Commercial Officer, Member of the Management Board
Chief Commercial Officer, Member of the Management Board
--
--
Mr. Dieter Weinand
Mr. Dieter Weinand
Chairwoman of the Supervisory Board
Chairwoman of the Supervisory Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--

FAQs

Who are the top five shareholders of Evotec SE?

The top five shareholders of Evotec SE are: Dr. Cord Dohrmann, Ph.D.

How many institutions hold shares of Evotec SE (EVO)?

As of 2026Q1, 81 institutions hold shares of Evotec SE, with a combined market value of approximately 9.58M, accounting for 2.69% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -584606.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.